Scientific American recently featured four stories on advancements in gene therapy.
The grants, totaling more than $8 million, will support seven high-risk, high-reward research projects
Interius BioTherapeutics has signed a 17,743 SF lease advancing cell and gene therapy research at the Pennovation Works innovation ecosystem.
The Washington Post ran two feature articles profiling Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, PhD, an adjunct professor of Neurosurgery.
The foundational work that enabled the use of messenger RNA (mRNA) in vaccine development that they're receiving the 2021 Dr. Paul Janssen Award for Biomedical Research,
Penn mRNA Scientists Drew Weissman and Katalin Karikó Receive 2021 Lasker Award, America’s Top Biomedical Research Prize
Drs. Weissman and Karikó’s mRNA technology is recognized for enabling rapid development of highly effective COVID-19 vaccines.
Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, PhD, an adjunct professor of Neurosurgery at Penn, have been awarded multiple prestigious prizes.
Luxturna inventor Jean Bennett starts a new gene therapy company to tackle rare diseases left behind by pharma, VCs
Jean Bennett, who designed and co-developed Luxturna, approved in 2018 for a rare form of blindness, had kept building new gene therapies for eye diseases at her University of Pennsylvania lab.
National Inventors Hall of Fame, in partnership with the United States Patent and Trademark Office, is excited to announce the 2022 Class of Inductees.
long with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate, a nanotechnology-enabled ocular implant to treat glaucoma.